“Say Goodbye to Bird Flu: Traws Pharma’s Tivoxavir Marboxil Completes Phase I Studies!”
Exciting News in the Fight Against Bird Flu! The Latest Breakthrough in Flu Treatment Have you heard the buzz about Traws Pharma, Inc.’s latest development in the world of influenza treatment? The company has just completed Phase I clinical studies of their groundbreaking one-dose influenza therapy, tivoxavir marboxil (tivoxavir), which shows promising results for the…